09/18/2026
Sidley Represents GSK in Connection With Its €3.5 Billion Issuance of Notes
GSK used the net proceeds from the offering to repay outstanding amounts under its acquisition facility related to its recently completed acquisition of Nuvalent, Inc., and for general corporate purposes.